Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Harvard Bioscience, Inc. HBIO

Full chart Compare
Set alert

Price alert · HBIO

All alert types
8.46 USD -0.17 (-1.97%)

At closeNov 5, 2026, 4:00 PM EST

8.46 0.00 0.00%

After hours · Nov 5, 4:00 PM ET

8.35 Day range 8.68
4.00 52-week range 9.10
YTD
+26.27%
1 year
+43.39%

Financial health

Altman Z-Score

-2.54 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 2

Valuation

P/E -0.5×
FY 2016: -23.5×FY 2017: -128×FY 2018: -32.9×FY 2019: -25.4×FY 2020: -21.4×FY 2021: -993×FY 2022: -12.0×FY 2023: -66.5×FY 2024: -7.5×FY 2025: -0.5×
FY 2016 5y median -12.0× FY 2025
P/S 0.3×
FY 2016: 1.0×FY 2017: 1.1×FY 2018: 0.9×FY 2019: 1.0×FY 2020: 1.6×FY 2021: 2.4×FY 2022: 1.0×FY 2023: 2.0×FY 2024: 1.0×FY 2025: 0.3×
FY 2016 5y median 1.0× FY 2025
P/B 2.2×
FY 2016: 1.4×FY 2017: 1.4×FY 2018: 1.4×FY 2019: 1.4×FY 2020: 2.2×FY 2021: 3.4×FY 2022: 1.6×FY 2023: 3.1×FY 2024: 1.5×FY 2025: 2.2×
FY 2016 5y median 2.2× FY 2025
P/FCF 5.3×
FY 2016: 26.7×FY 2017: 664×FY 2018: 83.9×FY 2019: 16.9×FY 2020: 20.3×FY 2021: 4245×FY 2022: -262×FY 2023: 19.4×FY 2024: -50.4×FY 2025: 5.3×
FY 2016 5y median 5.3× FY 2025
EV/EBITDA -1.4×
FY 2016: 62.5×FY 2017: 116×FY 2018: 30.9×FY 2019: 22.4×FY 2020: 41.6×FY 2021: 37.0×FY 2022: 174×FY 2023: 33.0×FY 2024: -102×FY 2025: -1.4×
FY 2016 5y median 33.0× FY 2025
EV/Sales 0.8×
FY 2016: 1.1×FY 2017: 1.1×FY 2018: 1.4×FY 2019: 1.5×FY 2020: 2.1×FY 2021: 2.8×FY 2022: 1.5×FY 2023: 2.4×FY 2024: 1.4×FY 2025: 0.8×
FY 2016 5y median 1.5× FY 2025
FCF Yield 18.9%
FY 2016: 3.7%FY 2017: 0.2%FY 2018: 1.2%FY 2019: 5.9%FY 2020: 4.9%FY 2021: 0.0%FY 2022: -0.4%FY 2023: 5.2%FY 2024: -2.0%FY 2025: 18.9%
FY 2016 5y median 0.0% FY 2025

Profitability

Gross Margin 53.0%
FY 2016: 46.3%FY 2017: 46.7%FY 2018: 52.3%FY 2019: 55.4%FY 2020: 56.8%FY 2021: 56.9%FY 2022: 53.7%FY 2023: 58.9%FY 2024: 58.2%FY 2025: 53.0%
FY 2016 5y median 56.9% FY 2025
Operating Margin -0.7%
FY 2016: -2.9%FY 2017: -0.1%FY 2018: 0.8%FY 2019: 0.3%FY 2020: 0.2%FY 2021: 1.7%FY 2022: -6.1%FY 2023: 1.7%FY 2024: -6.6%FY 2025: -0.7%
FY 2016 5y median -0.7% FY 2025
Net Margin -65.5%
FY 2016: -4.1%FY 2017: -0.8%FY 2018: -2.9%FY 2019: -4.0%FY 2020: -7.6%FY 2021: -0.2%FY 2022: -8.4%FY 2023: -3.0%FY 2024: -13.2%FY 2025: -65.5%
FY 2016 5y median -8.4% FY 2025
ROE -412.8%
FY 2016: -6.0%FY 2017: -1.1%FY 2018: -4.2%FY 2019: -5.7%FY 2020: -10.2%FY 2021: -0.3%FY 2022: -13.2%FY 2023: -4.7%FY 2024: -19.6%FY 2025: -412.8%
FY 2016 5y median -13.2% FY 2025
ROIC -1.0%
FY 2016: -3.1%FY 2017: -0.0%FY 2018: 0.4%FY 2019: 0.2%FY 2020: 0.2%FY 2021: 1.5%FY 2022: -5.4%FY 2023: 1.6%FY 2024: -5.7%FY 2025: -1.0%
FY 2016 5y median -1.0% FY 2025
ROA -70.8%
FY 2016: -4.0%FY 2017: -0.8%FY 2018: -2.1%FY 2019: -2.8%FY 2020: -5.0%FY 2021: -0.2%FY 2022: -6.5%FY 2023: -2.5%FY 2024: -9.8%FY 2025: -70.8%
FY 2016 5y median -6.5% FY 2025

Growth (YoY)

Revenue -8.1%
FY 2016: -3.8%FY 2017: -2.5%FY 2018: 18.5%FY 2019: -3.8%FY 2020: -12.1%FY 2021: 16.5%FY 2022: -4.7%FY 2023: -1.0%FY 2024: -16.1%FY 2025: -8.1%
FY 2016 FY 2025
Operating Income 89.9%
FY 2016: -75.0%FY 2017: 96.6%FY 2018: 1074.3%FY 2019: -61.7%FY 2020: -41.4%FY 2021: 834.8%FY 2022: -435.6%FY 2023: 127.3%FY 2024: -427.9%FY 2025: 89.9%
FY 2016 FY 2025
EPS (diluted) -357.1%
FY 2016: 77.2%FY 2017: 80.8%FY 2018: -281.5%FY 2019: -26.3%FY 2020: -66.7%FY 2021: 96.5%FY 2022: -3139.4%FY 2023: 65.0%FY 2024: -247.8%FY 2025: -357.1%
FY 2016 FY 2025
Free Cash Flow 408.0%
FY 2016: 271.8%FY 2017: -95.7%FY 2018: 713.2%FY 2019: 403.0%FY 2020: 19.7%FY 2021: -99.2%FY 2022: -753.7%FY 2023: 2775.1%FY 2024: -115.6%FY 2025: 408.0%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 3.1×FY 2017: 3.4×FY 2018: 2.5×FY 2019: 2.1×FY 2020: 2.5×FY 2021: 2.4×FY 2022: 2.2×FY 2023: 1.8×FY 2024: 0.8×FY 2025: 2.2×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 1.2×
FY 2016: 1.7×FY 2017: 1.9×FY 2018: 1.4×FY 2019: 1.2×FY 2020: 1.4×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.4×FY 2025: 1.2×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 3.2×
FY 2016: 0.2×FY 2017: 0.1×FY 2018: 0.7×FY 2019: 0.8×FY 2020: 0.8×FY 2021: 0.7×FY 2022: 0.8×FY 2023: 0.6×FY 2024: 0.7×FY 2025: 3.2×
FY 2016 5y median 0.7× FY 2025
Net Debt / EBITDA -0.8×
FY 2016: 4.5×FY 2017: 6.0×FY 2018: 9.8×FY 2019: 7.3×FY 2020: 9.5×FY 2021: 5.4×FY 2022: 52.7×FY 2023: 4.8×FY 2024: -31.1×FY 2025: -0.8×
FY 2016 5y median 4.8× FY 2025
Interest Coverage -0.1×
FY 2016: -4.7×FY 2017: -0.1×FY 2018: 0.2×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 1.3×FY 2022: -2.7×FY 2023: 0.5×FY 2024: -1.9×FY 2025: -0.1×
FY 2016 5y median -0.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31